Access our full library of resources, register for events and webinars and share audits and other assessments
CPHI & PMEC China brings together suppliers and buyers across the entire pharma supply chain, in the home of modern medicine. Position your business as a key player in a thriving market and access a market built on rapid innovation. Join us in Shanghai to network, source cost-effective solutions, and conduct vital face-to-face business.
PSCI Members will be speaking at the event. For more information, check out the agenda.
The PSCI Spring Meeting 2026 took place on the 21st and 22nd of April in Basel, Switzerland, hosted by Roche. We were joined by 180 members, both in-person and virtually, to explore this year's theme of Transformational Impact.
Recordings and the report back are available to PSCI Members.
The PSCI is delighted to be an Official Sustainability Partner for CPHI Milan, the biggest international pharma industry event.
We'll be exhibiting throughout the conference in Milan from 6-8 October, and attending the inaugural CPHI Sustainability Summit on Monday 5 October.
The PSCI stand H47 will be located in Hall 16, where we will be showcasing the impact that the PSCI has through the pharmaceutical supply chain.
Meet with us on-site
Please contact the Secretariat if you are planning to attend and would like to arrange a meeting.
The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2025 Annual Report, celebrating continued growth in Membership, record audit sharing, and increased reach in Asia. The PSCI held its first Member Meeting in Shanghai, China, and celebrated 10 years of the India Supplier Conference alongside the delivery of four technical workshops across the sub-continent. These efforts aim to ensure continued progress towards responsible supply chain practices in key sourcing regions for the industry.
The PSCI is powered by 81 Members who represent 70% of the pharma industry and more than $1.2tn revenue collectively. It exists to advance and embed responsible practices in the pharmaceutical, life science, and healthcare supply chains. The PSCI’s Members work together to uphold the PSCI Principles for Responsible Supply Chain Management and collaborate through the association’s strategic focus on Audits, Capability-building, and Projects.
Reflecting on the previous year, the 2025 PSCI Annual Report reached significant milestones in the journey to embed responsible practices in the pharmaceutical value chain.
Rob Williams, 2025 PSCI Chair says,
2025 was another impactful year for the PSCI. We grew our presence key sourcing locations throughout Asia and delivered a first-ever Decarbonization Summit to bring the industry together to make practical decarbonization a reality. The audits on our platform continue to grow and our annual analysis of findings provides deep insight into responsible supply chain issues and regional trends in key sourcing locations around the world. Celebrating 10 years of the India Supplier Conference and reaching an even greater number of suppliers through regional technical workshop shows the breadth and depth of our work; and our first-ever Japanese webinar on PiE/AMR was a fantastic contribution towards expanding our support for the Japanese market. The PSCI Membership is truly building responsible supply chains.
Reflecting on the previous year, the 2025 PSCI Annual Report showcases significant milestones in the journey to embed responsible practices in the pharmaceutical value chain.
The PSCI held its first Member Meeting in Shanghai, China, and celebrated 10 years of the India Supplier Conference alongside the delivery of four technical workshops across the sub-continent. These efforts aim to ensure continued progress towards responsible supply chain practices in key sourcing regions for the industry.
The PSCI is powered by 81 Members who represent 70% of the pharma industry and more than $1.2tn revenue collectively. It exists to advance and embed responsible practices in the pharmaceutical, life science, and healthcare supply chains. The PSCI’s Members work together to uphold the PSCI Principles for Responsible Supply Chain Management and collaborate through the association’s strategic focus on Audits, Capability-building, and Projects.
Japan is Asia’s engine for advanced drug discovery, a global leader in innovation, quality, and regulatory excellence. As the world’s third-largest pharma market, it’s home to groundbreaking R&D, high production standards, and unmatched trust in healthcare.
PSCI Members Wenjia Xu and Kozo Ohashi will be presenting on the Threat of AMR and Pharmaceutical Responsibility: Industry-Wide Initiatives and SHIONOGI Group Actions.
This presentation follows on from the successful webinar on this subject that took place in December 2025. Additional information about the PSCI and our mission and vision will also be presented.
The presentation will take place on 21 April. To register for the session, click here.
About CPHI Japan
CPHI Japan provides connections to the thriving ecosystem and access to the companies, insights, and opportunities shaping the future of pharmaceuticals across Asia Pacific.
Japan is Asia’s engine for advanced drug discovery, a global leader in innovation, quality, and regulatory excellence. As the world’s third-largest pharma market, it’s home to groundbreaking R&D, high production standards, and unmatched trust in healthcare.
CPHI Japan connects you to this thriving ecosystem, giving you access to the companies, insights, and opportunities shaping the future of pharmaceuticals across Asia Pacific.
In the modern chemical and pharmaceutical landscape, reactive chemical hazards represent one of the most significant risks to process safety and business continuity. Undetected thermal instabilities or improperly sized relief systems can lead to catastrophic runaway reactions, resulting in loss of life, environmental damage, and total asset loss. This intensive two-day workshop, led by industry experts from Kaypear in collaboration with the PSCI, provides a comprehensive roadmap for identifying, quantifying, and mitigating reactive risks.
Registration Process
If you are interested in attending this workshop, please register your interest below. Registration does not guarantee a place. Your attendance will be confirmed in due course. Please note that attendance is limited to one person per organization.
Who should attend
As this is a core technical topic, professionals with the following qualifications and job roles are requested to register:
Day 1
Day 2
Speakers
Mr. Rahul Raman
Rahul Raman is Principal Engineer and Subject Matter Expert at Kaypear with over 19 years of global expertise in process safety management (PSM) across the United States, Mexico, China, South Korea, and India. A Chartered Chemical Engineer with a Master's degree from Carnegie Mellon University and a B.Tech in Chemical Engineering from Anna University, he specializes in emergency relief system design, technical process safety, and process safety management implementation. Rahul has successfully led major projects in oil and gas, petrochemical, and chemical industries, including relief system gap assessments, HAZOP studies, quantitative risk assessments, and implementing process safety standards.
Mr. Pramod Mekhya
Mr. Pramodbhai Mekhya is a seasoned Chemical Engineer and Process Safety Specialist with over 19 years of industrial experience spanning process development, process safety, scale-up, and advanced calorimetry techniques in the pharmaceutical and chemical industries.
He has extensive hands-on expertise in thermal hazard assessment, reaction calorimetry, adiabatic calorimetry, and process scale-up, supporting both R&D laboratories and manufacturing plants to design safer and more efficient chemical processes. He brings a rare combination of industrial manufacturing experience and advanced safety instrumentation expertise, enabling participants to gain practical insights into reaction hazard evaluation, calorimetry data interpretation, and safe process scale-up strategies.
The Principles are designed to remain high‑level and applicable across a diverse global membership, providing clarity, supporting continuous improvement, and ensuring relevance over a three‑year review cycle.
External consultation is now open
We invite external stakeholders to share input through our consultation survey HERE
To support consistency, we ask contributors to propose up to one significant and up to three minor refinements.
Further detail on the review process and timeline can be found HERE
We encourage all stakeholders to participate and help shape the future direction of responsible supply chain management across the sector.
Get a quick update on the latest PSCI news, including the PSCI Principles Review, the PSCI Supplier Decarbonization Help Desk, webinars, new learning courses, and more.